White House & Policy - July 22, 2026 (EOD)

 ## Policy Recap The administration took significant steps today in advancing U.S. energy and technology policy, alongside legislative activity aimed at stabilizing government funding. Notably, the president approved a landmark nuclear energy pact with Saudi Arabia, signaling a strategic pivot toward expanding nuclear power cooperation in the Middle East. This move aligns with broader efforts to diversify energy sources and strengthen geopolitical alliances. Additionally, the administration is reportedly exploring the placement of nuclear power plants in U.S. federal waters, which could accelerate domestic nuclear infrastructure development and support clean energy goals. Congressional activity also influenced market dynamics as the House passed a stopgap funding bill to keep the government operational through early December. This legislative action averted an immediate government shutdown, reducing near-term fiscal uncertainty. Meanwhile, Senate committees advanced a China auto bill that could restrict certain foreign vehicle imports, reflecting ongoing trade and national security concerns. The administration’s push for tariffs on generic drugs starting in 2028 also surfaced, aiming to bolster domestic pharmaceutical manufacturing but raising questions about drug pricing and supply chains. Throughout the trading session, markets digested these policy developments with a focus on energy security, technology investment, and fiscal stability. The nuclear pact with Saudi Arabia and potential domestic nuclear plant initiatives were viewed as positive catalysts for energy and industrial sectors. Conversely, tariff threats on generics and trade restrictions on Chinese vehicles introduced caution in healthcare and auto-related stocks. The stopgap funding bill helped stabilize risk sentiment by removing immediate government funding risks. ## Market Reaction U.S. equity markets showed mixed performance in response to the policy news. The S&P 500 experienced late-session gains, supported by strong earnings from major tech companies and optimism around infrastructure and energy initiatives. However, futures indicated some caution ahead of key tech earnings reports, reflecting investor focus on capital expenditure and regulatory risks. The Dow Jones Industrial Average was weighed down by rising oil prices amid Middle East tensions, while the Nasdaq faced pressure from profit-taking in AI-related stocks. In fixed income, Treasury yields remained relatively flat as investors balanced inflation concerns against geopolitical risks. The two-year Treasury yield hit a 17-month high earlier but settled as the session progressed, reflecting uncertainty about the Fed’s next moves amid mixed economic signals. The U.S. dollar showed little change overall, despite renewed trade uncertainty and currency intervention talks in Japan due to the yen’s 40-year low. Oil prices climbed over 4%, driven by escalating Middle East conflict and supply route threats, adding inflationary pressure and influencing energy sector performance. Intraday swings were notable around the announcement of the U.S.-Saudi nuclear pact and the House’s passage of the stopgap funding bill. The nuclear deal boosted energy and industrial stocks, while the funding bill calmed volatility related to government shutdown fears. Overall, risk sentiment shifted cautiously positive, with investors weighing the benefits of energy diversification and fiscal stability against geopolitical and trade-related headwinds. ## Sector Scorecard - **Energy (XLE):** The energy sector rallied on the administration’s nuclear energy pact with Saudi Arabia and exploration of domestic nuclear plants. Rising oil prices amid Middle East tensions further supported the sector. Kinder Morgan (**$KMI**) reported strong Q2 results, beating earnings and revenue estimates, reinforcing positive sentiment in energy infrastructure. - **Industrials (XLI):** Industrials gained as the nuclear pact and infrastructure spending prospects lifted expectations for power and defense-related companies. Orders and margins in industrial firms tied to energy and AI infrastructure showed strength, contributing to sector gains. - **Technology (XLK):** Technology stocks had a mixed day. While Alphabet (**$GOOGL**) beat Q2 earnings estimates with strong cloud revenue growth, its shares fell on concerns over increased capital expenditure. Super Micro Computer (**$SMCI**) surged late in the session on strong AI-related order growth, lifting sentiment in AI infrastructure names. - **Healthcare (XLV):** Healthcare faced headwinds from the administration’s proposed tariffs on generic drugs, which weighed on pharmaceutical stocks. Sandoz and other drugmakers saw share declines amid tariff concerns. However, some biotech firms with strong pipeline progress showed resilience. - **Financials (XLF):** Financials were supported by strong earnings from major banks like JPMorgan (**$JPM**), which posted record quarterly profits. The stopgap funding bill also reduced near-term fiscal risk, aiding financial sector stability. ## Winners & Losers ### Today's Policy Winners - **$KMI** +3.5% - Benefited from strong Q2 earnings and positive sentiment from nuclear energy initiatives. - **$SMCI** +7.2% - Surged on AI infrastructure demand and strong order growth signaling tech investment tailwinds. - **$JPM** +2.1% - Boosted by record profits and reduced fiscal uncertainty from government funding bill. ### Today's Policy Losers - **$SNDK** -4.0% - Declined amid tariff concerns and margin pressure linked to U.S. generic drug tariff proposals. - **$AT&T** -2.5% - Despite beating earnings estimates, shares fell due to concerns over leverage and tariff-related risks. - **$PEGAS** -5.3% - Shares tumbled on Q2 results miss and broader tech margin pressure related to AI spending. ## Trade & Tariff Update The administration’s announcement of planned tariffs on generic drugs starting in 2028 created notable market reactions. Pharmaceutical companies with significant generic drug exposure, including Sandoz, saw share price declines. The tariffs aim to incentivize domestic production but raise concerns about drug costs and supply chain disruptions. Separately, the Senate advanced a China auto bill that could bar certain Chinese vehicles from the U.S. market. This development added pressure on auto manufacturers and suppliers with China exposure. Trade-sensitive companies monitored these developments closely, with some industrial and auto-related stocks experiencing volatility. No new tariff measures on steel or aluminum were reported today, but the administration’s ongoing review of tariffs and trade policies continues to influence market sentiment, especially in sectors reliant on global supply chains. ## Tomorrow's Policy Calendar - Treasury to release updated inflation and employment data, key for Fed policy outlook. - Congressional committee hearing on semiconductor supply chain security and U.S.-China trade relations. - Pending executive order on AI regulation and data privacy expected to be announced. - Senate vote scheduled on the China auto import restriction bill. - Administration speech on infrastructure and clean energy investment plans.